|
|
Volumn 17, Issue SUPPL. F, 1996, Pages 16-29
|
|
Treatment for acute myocardial infarction. Overview of randomized clinical trials
a
|
|
Author keywords
Acute myocardial infarction; Drug treatment; Randomized clinical trials
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANISTREPLASE;
ANTIARRHYTHMIC AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRILAT;
FIBRINOLYTIC AGENT;
GLYCERYL TRINITRATE;
HEPARIN;
HIRUDIN;
HIRULOG;
LIDOCAINE;
LISINOPRIL;
LOW MOLECULAR WEIGHT HEPARIN;
MAGNESIUM;
METOPROLOL;
NIFEDIPINE;
NITRATE;
NITROPRUSSIDE SODIUM;
RAMIPRIL;
RETEPLASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
TRANDOLAPRIL;
VERAPAMIL;
ACUTE HEART INFARCTION;
ANGINA PECTORIS;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FIBRINOLYTIC THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MEDICAL DECISION MAKING;
META ANALYSIS;
MORBIDITY;
MORTALITY;
ORAL DRUG ADMINISTRATION;
PATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0029797135
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/17.suppl_f.16 Document Type: Conference Paper |
|
Times cited : (40)
|
|
References (0)
|
